Morgan Stanley’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19K | Buy |
+584
| New | +$1.19K | ﹤0.01% | 7315 |
|
2025
Q1 | – | Sell |
-14
| Closed | -$24 | – | 8118 |
|
2024
Q4 | $24 | Sell |
14
-14
| -50% | -$24 | ﹤0.01% | 7829 |
|
2024
Q3 | $125 | Hold |
28
| – | – | ﹤0.01% | 7414 |
|
2024
Q2 | $120 | Hold |
28
| – | – | ﹤0.01% | 7332 |
|
2024
Q1 | $117 | Sell |
28
-28
| -50% | -$117 | ﹤0.01% | 7362 |
|
2023
Q4 | $256 | Buy |
56
+27
| +93% | +$123 | ﹤0.01% | 7329 |
|
2023
Q3 | $126 | Buy |
+29
| New | +$126 | ﹤0.01% | 7426 |
|
2023
Q1 | – | Sell |
-196
| Closed | -$2.96K | – | 7745 |
|
2022
Q4 | $2.96K | Buy |
196
+26
| +15% | +$393 | ﹤0.01% | 7271 |
|
2022
Q3 | $1K | Hold |
170
| – | – | ﹤0.01% | 7557 |
|
2022
Q2 | $2K | Hold |
170
| – | – | ﹤0.01% | 7581 |
|
2022
Q1 | $4K | Sell |
170
-39
| -19% | -$918 | ﹤0.01% | 7626 |
|
2021
Q4 | $8K | Buy |
209
+180
| +621% | +$6.89K | ﹤0.01% | 7528 |
|
2021
Q3 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 7767 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 6596 |
|
2019
Q4 | – | Sell |
-838
| Closed | -$37K | – | 6672 |
|
2019
Q3 | $37K | Sell |
838
-1,638
| -66% | -$72.3K | ﹤0.01% | 5828 |
|
2019
Q2 | $122K | Buy |
+2,476
| New | +$122K | ﹤0.01% | 5232 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 6612 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 6621 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 6727 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 6682 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 6633 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 6584 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 6547 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 6600 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 6581 |
|
2016
Q3 | – | Sell |
-2
| Closed | -$2K | – | 6516 |
|
2016
Q2 | $2K | Buy |
2
+1
| +100% | +$1K | ﹤0.01% | 6362 |
|
2016
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 6464 |
|